Status:

COMPLETED

Objective Sepsis Identification Tool to Study Sepsis Epidemiology

Lead Sponsor:

Chinese University of Hong Kong

Conditions:

Sepsis

Eligibility:

All Genders

18+ years

Brief Summary

Globally, sepsis affects an estimated 31.5 million people and accounts for 5.3 million deaths each year. This calculation is based on data from western high income countries only. The purpose of this ...

Detailed Description

Globally, sepsis affects an estimated 31.5 million people and accounts for 5.3 million deaths each year. The incidence of sepsis is increasing and is now a more common cause for hospital admission tha...

Eligibility Criteria

Inclusion

  • January 2018 to February 2018 adult inpatients at Prince of Wales Hospital
  • 1st microbiological culture tests during hospital admission

Exclusion

  • duplicated microbiological sampling
  • missing values for sequential organ failure assessment score calculation
  • microbiological tests were for screening only (methicillin-resistant staphylococcus aureus swabs, vancomycin resistant Enterococci rectal swab)
  • antibiotics not started 2 days before or after first microbiological sampling
  • antibiotics duration less than 4 days unless death
  • not given antibiotics on discharge if given less than 4 days antibiotics in hospital

Key Trial Info

Start Date :

September 10 2019

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

October 15 2019

Estimated Enrollment :

490 Patients enrolled

Trial Details

Trial ID

NCT04114214

Start Date

September 10 2019

End Date

October 15 2019

Last Update

May 6 2020

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Prince of Wales Hospital

Hong Kong, Hong Kong